十二指肠内联合给予月桂酸与L-色氨酸对2型糖尿病餐后血糖、糖调节激素及胃排空的影响:双盲随机交叉研究
该双盲随机交叉研究在11例2型糖尿病男性中评估十二指肠内输注月桂酸(C12)、L-色氨酸(Trp)、C12+Trp或生理盐水对餐后血糖的影响。结果显示仅C12+Trp降低整体及峰值血糖,并减慢胃排空、升高餐前GLP-1、GIP和CCK,而不影响胰岛素或C肽。结论提示C12+Trp可能主要通过减慢胃排空和GLP-1/CCK介导降低餐后血糖。
要点
- 在2型糖尿病男性中,十二指肠内联合输注C12+Trp可降低餐后整体及峰值血糖。
- C12+Trp减慢胃排空并升高餐前GLP-1、GIP和CCK,不改变胰岛素或C肽。
- 单独C12或Trp无效,提示联合营养策略值得进一步探索。
核心结论
- 在2型糖尿病中,十二指肠内C12+Trp降低餐后血糖,可能主要因减慢胃排空并由GLP-1和CCK介导。
- 研究支持进一步探索基于营养的胃肠道策略以优化2型糖尿病血糖管理。
研究设计与样本
- 随机、双盲(研究者和参与者)、交叉研究,在阿德莱德大学临床研究设施进行。
- 11例2型糖尿病男性(年龄69±7岁;HbA1c 51±5 mmol/mol [6.8±0.3%];BMI 28±1 kg/m2)。
- 每例在四个不同场合接受45分钟十二指肠内输注C12(1.26 kJ/min)、Trp(0.42 kJ/min)、C12+Trp(1.68 kJ/min)或0.9%生理盐水,于混合营养素饮料前30分钟。
主要发现
- C12+Trp降低整体(p=0.02)和峰值(mmol/l;对照11.1±0.6,Trp 10.3±0.5,C12 10.7±0.6,C12+Trp 9.8±0.5;p=0.01)血浆葡萄糖。
- C12+Trp减慢胃排空(p=0.001),并升高餐前血浆GLP-1、GIP和CCK(均p<0.05),不影响胰岛素或C肽。
- 餐后未观察到治疗效应。
临床怎么用
- 联合十二指肠内给予C12+Trp可能作为降低2型糖尿病餐后血糖的营养性策略,但需进一步研究验证。
局限性
- 研究仅纳入11例2型糖尿病男性,样本量小。
- 干预为十二指肠内输注,非口服,临床可行性受限。
- 餐后未观察到激素或血糖的治疗效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: In healthy men, lauric acid (C12) and L-tryptophan (Trp), when administered intraduodenally in loads of 1.26 and 0.42 kJ/min (0.3 and 0.1 kcal/min), respectively, that are individually ineffective, stimulate glucagon-like peptide-1 (GLP-1) and cholecystokinin (CCK), when combined. Both hormones slow gastric emptying, suppress energy intake and lower postprandial glucose. We have now investigated the hypothesis that combined intraduodenal administration of these nutrients reduces postprandial glucose in type 2 diabetes. METHODS: In a randomised, blinded (investigators and participants), crossover study performed in the University of Adelaide Clinical Research Facility, 11 men with type 2 diabetes (age: 69 ± 7 years; HbA1c: 51 ± 5 mmol/mol [6.8 ± 0.3%]; BMI: 28 ± 1 kg/m2), each received, on four separate occasions, 45 min intraduodenal infusions of C12 (1.26 kJ/min), Trp (0.42 kJ/min), C12+Trp (1.68 kJ/min), or 0.9% saline (control), 30 min before a mixed-nutrient drink (350 ml, 2092 kJ (500 kcal), 74 g carbohydrate) containing 100 mg 13C-acetate. Plasma glucose, GLP-1, glucose-dependent insulinotropic polypeptide (GIP), insulin, C-peptide and CCK concentrations were measured at baseline, following treatments alone, and for 180 min post-drink. Gastric emptying was assessed via 13C-acetate breath test. RESULTS: C12+Trp, but not C12 or Trp, reduced overall (p=0.02) and peak (mmol/l; control: 11.1 ± 0.6, Trp: 10.3 ± 0.5, C12: 10.7 ± 0.6, C12+Trp: 9.8 ± 0.5; p=0.01) plasma glucose. C12+Trp slowed gastric emptying (p=0.001), and increased pre-drink plasma GLP-1, GIP and CCK (all p<0.05), without affecting insulin or C-peptide. No treatment effects were observed postprandially. CONCLUSIONS/INTERPRETATION: In type 2 diabetes, intraduodenal C12+Trp lowers postprandial glucose, probably primarily by slowing of gastric emptying and mediated by GLP-1 and CCK. These findings support further exploration of nutrient-based gastrointestinal strategies to optimise glycaemic management in type 2 diabetes. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ( www.anzctr.org.au ) ACTRN12623000778684 FUNDING: JAS and VB were each supported by Adelaide Scholarship International stipends, provided by the University of Adelaide (JAS, 2021-2025; VB, 2017-2020) and CFB by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship (Grant 1103020, 2016-2023). The research was supported by a Diabetes Australia Research Project Grant (2021-2022) to CFB.
引用
- Anjom-Shoae J, Fitzgerald PCE, Rose BD, et al. Effects of combined intraduodenal administration of lauric acid and L-tryptophan on postprandial plasma glucose, glucoregulatory hormones and gastric emptying in type 2 diabetes: a double-blind, randomised, crossover study. Diabetologia. 2025. PMID: 41419616. doi:10.1007/s00125-025-06630-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。